Kolexia
Ittel Antoine Pharmacien
Ittel Antoine
Pharmacien
Centre Paoli-Calmettes
Marseille, France
35 Activités
125 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie myéloïde Aberrations des chromosomes Lymphomes Leucémie-lymphome lymphoblastique à précurseurs B et T Leucémie aigüe myéloïde Translocation génétique Syndromes myélodysplasiques Leucémie prolymphocytaire à cellules B

Collaborateurs

Voir plus
Mauvieux Laurent
Mauvieux Laurent
Hôpital Hautepierre, Strasbourg, France
Gervais Carine
Gervais Carine
Hôpital Hautepierre, Strasbourg, France
Mozziconacci Marie-Joelle
Mozziconacci Marie-Joelle
Centre Paoli-Calmettes, Marseille, France
Vey Norbert
Vey Norbert
Centre Paoli-Calmettes, Marseille, France

Industries

Voir plus
Janssen
8 collaboration(s)
Dernière en 2023
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Azacitidine-venetoclax versus azacitidine salvage treatment for primary induction failure or first relapsed acute myeloid leukaemia patients.
European journal of haematology   29 novembre 2023
Poor Prognosis of SRSF2 Gene Mutations in Patients Treated with Venetoclax-Azacitidine (VEN-AZA) for Newly Diagnosed Acute Myeloid Leukemia. a Multicentric Real-Life Study of 117 Patients
65th ASH Annual Meeting Abstracts   02 novembre 2023
Clinical, Cytogenetic and Molecular Characterization of a 96 MDS and AML Cohort with TP53 Mutation
65th ASH Annual Meeting Abstracts   02 novembre 2023
Efficacy of Chemo-Free Combination Therapy with BRAF Inhibitor and Rituximab in Classic Hairy Cell Leukemia: Insights from the French Experience
65th ASH Annual Meeting Abstracts   02 novembre 2023
Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients.
Cancers   16 avril 2022
The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.
Blood advances   05 avril 2022
Multiple cytogenetics forms of amplification and jumping translocation in a case of myelodysplastic syndrome.
EJHaem   12 octobre 2021
Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.
British journal of haematology   13 décembre 2020
Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53.
Blood   28 février 2020
Isolated isochromosomes i(X)(p10) and idic(X)(q13) are associated with myeloid malignancies and dysplastic features.
American journal of hematology   26 août 2019